Virginia · J2250

Injection, Midazolam Hydrochloride, Per 1 Mg in Virginia

Virginia Medicare Avg
$0.12
2% above national avg
National Medicare Avg
$0.12
All states combined
Billed Charge (VA)
$14.13
What providers submit
Est. Commercial (VA)
$0.33
National avg: $0.34
Est. Cash / Self-Pay (VA)
$4.00
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

12.7K
Services in VA
84
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Virginia

Provider Medicare Services
Zafar, Usman M.D. $0.12 1.3K
Heller, Daniel M.D. $0.12 1.3K
Lee, Rick MD $0.12 1.1K
Ramesh, Arjun M.D. $0.12 753
Joiner, Murray MD $0.12 621
Khan, Nadeem MD $0.12 560
Bassam, Deeni M.D. $0.12 501
Kendall, Daniel DO $0.13 500
Holland, Matthew MD $0.12 462
Pavidapha, Alex M.D $0.12 434
Ung, Chheany M.D. $0.12 390
Mcbee, Claude M.D. $0.12 370

Virginia Pricing in Context

In Virginia, CPT code J2250 (Injection, Midazolam Hydrochloride, Per 1 Mg) carries an average Medicare payment of $0.12 — 2% above the national benchmark of $0.12. 84 providers across the state submitted claims for this procedure in 2023, performing 12.7K total services. Individual payments in VA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Virginia is $14.13, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Virginia sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Drugs (Administered) procedures, the estimated commercial insurance price in Virginia lands near $0.33, with self-pay cash prices typically around $4.00. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Injection, Midazolam Hydrochloride, Per 1 Mg cost in Virginia?

The average Medicare payment for Injection, Midazolam Hydrochloride, Per 1 Mg in Virginia is $0.12, which is 2% above the national average of $0.12. Providers in VA typically bill $14.13 for this procedure.

What does Injection, Midazolam Hydrochloride, Per 1 Mg cost with insurance in Virginia?

With commercial insurance in Virginia, Injection, Midazolam Hydrochloride, Per 1 Mg costs an estimated $0.33. Without insurance, the estimated cash price is $4.00. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Injection, Midazolam Hydrochloride, Per 1 Mg in Virginia?

84 providers in Virginia billed Medicare for Injection, Midazolam Hydrochloride, Per 1 Mg in 2023, performing 12.7K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Injection, Midazolam Hydrochloride, Per 1 Mg cheaper in Virginia than the national average?

No — Injection, Midazolam Hydrochloride, Per 1 Mg costs 2% above the national average in Virginia. The state average Medicare payment is $0.12 compared to $0.12 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial